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Background:  Peripheral arterial disease (PAD) is a common manifestation of systemic atherosclerosis and is associated with 
significant morbidity and mortality. Diabetes is known to increase the risk of PAD two- to four-fold. The prevalence of PAD in 
Korean diabetic patients has not been established. In this study, we investigated the prevalence of PAD in Korean patients with 
type 2 diabetes attending a large university hospital and analyzed the factors associated with PAD.
Methods:  A total of 2,002 patients with type 2 diabetes who underwent ankle-brachial index (ABI) measurement in an outpa-
tient clinic were enrolled. PAD was defined as an ABI ≤0.9. Clinical characteristics of 64 patients with PAD were compared with 
those of 192 age- and sex-matched control patients without PAD.
Results:  Of the 2,002 type 2 diabetic patients, 64 (3.2%) were diagnosed as having PAD. PAD was associated with higher preva-
lences of retinopathy, nephropathy, neuropathy, cerebrovascular and coronary artery disease. Patients with PAD had higher sys-
tolic blood pressure and serum triglyceride level and reported higher pack-years of smoking. Multivariate analysis showed that 
the presence of micro- and macrovascular complications and high systolic blood pressure are factors independently associated 
with PAD. 
Conclusion:  The prevalence of PAD in diabetic patients was 3.2%, suggesting that the prevalence in Korean diabetic patients is 
lower than that of patients in Western countries. 
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INTRODUCTION
Peripheral arterial disease (PAD), atherosclerotic occlusion of 
the arteries to the legs, is an important manifestation of system-
ic atherosclerosis [1]. Both symptomatic and asymptomatic 
PAD are associated with a significantly increased risk for car-
diovascular mortality [2]. It has been reported that patients 
with PAD, even in the absence of a history of myocardial in-
farction or ischemic stroke, have approximately the same rela-
tive risk of death from cardiovascular causes as do patients 
with a history of coronary or cerebrovascular disease [3].
  One of the objective measures of PAD is the ankle-brachial 
index (ABI), defined as the ratio between the systolic arterial 
pressure at the ankle level and that in the left or right brachial 
artery [4]. PAD is defined as an ABI ≤0.9 [5]. This measure-
ment is valuable for early detection of PAD and is also an indi-
cator of generalized atherosclerosis [6]. 
  It has been reported that diabetes is associated with a two- 
to four-fold increase in the incidence of PAD compared with 
that in non-diabetic subjects [7]. Among the U.S. adult popu-
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lation ≥40 years of age, the prevalence of PAD is 9.5% in dia-
betic subjects, two-fold higher than the 4.5% prevalence in 
non-diabetic subjects [8]. Accordingly, the American Diabetes 
Association (ADA) consensus statement recommends that 
ABI should be performed as a screening measure in all diabet-
ic individuals >50 years of age [9]. 
  While many PAD studies have been conducted in Western 
countries, little is known about the prevalence of PAD in Asian 
populations. PAD-SEARCH (peripheral arterial disease – 
screening and evaluation of diabetic patients in Asian regions 
characterized by high risk factors), the first international study 
to investigate the prevalence of PAD in Asian type 2 diabetic 
patients, reported that 11.7% of Asian patients with type 2 dia-
betes have PAD [10]. However, this study may have not reflected 
the general prevalence of PAD in Asian type 2 diabetic patients 
because it included only type 2 diabetic patients over 50 years 
of age having one or more risk factors such as smoking, hyper-
tension or dyslipidemia. The aim of the present study was to 
investigate the prevalence of PAD in Korean type 2 diabetic 
patients attending a university hospital and to characterize the 
factors associated with PAD. 
METHODS
Study subjects
 The study subjects consisted of 2,002 consecutive type 2 dia-
betic patients who underwent ABI measurement at the Diabe-
tes Center of Asan Medical Center between February and July 
2009. Type 2 diabetes was defined as onset age ≥25 years and 
fasting C-peptide level >1.0 ng/mL. Among the 2,061 patients 
in whom ABI was measured during the study period, 59 pa-
tients with the following conditions were excluded from the 
study: 1) onset age younger than 25 years (n=14), 2) type 1 di-
abetes (n=30), and 3) an ABI >1.4 (n=15). The study protocol 
was approved by the Institutional Review Board of Asan Med-
ical Center.
Study design
We analyzed the prevalence of PAD in all type 2 diabetic pa-
tients who underwent ABI during the study period. To char-
acterize the factors associated with PAD, we performed a case-
control study. For each patient with PAD, we selected age- and 
sex-matched control patients without PAD and retrospectively 
examined the medical records. We obtained information about 
age, sex, body mass index (BMI), duration of diabetes, systolic 
blood pressure (SBP), diastolic blood pressure (DBP), fasting 
plasma glucose (FBS), 2-hour postprandial glucose (2hPG), 
C-peptide, hemoglobin A1c (HbA1c), total cholesterol, high 
density lipoprotein (HDL) cholesterol, low-density lipoprotein 
(LDL) cholesterol, triglycerides, smoking history, and various 
complications of diabetes. All laboratory results were based on 
the tests performed on the day of the ABI exam. Diabetic reti-
nopathy included both non-proliferative and proliferative reti-
nopathy diagnosed by the ophthalmologist. Diabetic nephrop-
athy included microalbuminuria (defined as an albumin-to-
creatinine ratio between 30 and 300 μg/mg in a random urine 
spot collection), overt proteinuria (defined as an albumin-to-
creatinine ratio >300 μg/mg), and azotemia. Diabetic neurop-
athy was defined as having typical symptoms and/or evidence 
of reduced vibratory sensation or impairment on nerve con-
duction. Diagnosis of cerebrovascular (CVA) and coronary 
artery disease (CAD) were dependent on a history of ischemic 
events and/or demonstration of vascular stenosis by radiologic 
or other measures (i.e., brain magnetic resonance imaging 
[MRI], coronary angiography, or coronary computerized to-
mography [CT]). All results of the diagnostic tests were based 
on the final examinations on the day of the ABI exam.
Measurement of the ABI
The ABI was calculated for each leg by dividing the SBP ob-
tained at the ankle level in the respective leg by the SBP of the 
brachial artery. Measurements were performed with the par-
ticipants in the supine position. The examination was performed 
by trained technicians using VP-1000
® (Colin Co., Komaki, 
Japan). 
Assessment of PAD
The lesser ABI of the two legs was used to determine the pres-
ence of PAD because disease often occurs unilaterally. We used 
an ABI ≤0.9 as a criterion for the diagnosis of PAD according 
to the guidelines of the American College of Cardiology and 
the American Heart Association (ACC/AHA) [5]. This cut-off 
point has a sensitivity of 95% and a specificity of 99% for de-
tecting a significant stenotic limb lesion (at least 50% of arteri-
al lumen) [11]. An ABI ≤0.4 was regarded as severe PAD [1,5]. 
Statistical analysis
 Data were analyzed using the software program SPSS version 
15.0 (SPSS Inc., Chicago, IL, USA) and SAS software package 
version 9.1 (SAS Inc., Cary, NC, USA). Continuous variables 545
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were expressed as the mean±standard deviation, and categori-
cal variables as a percentage. Student’s t-test and the chi-square 
test were used to compare continuous and categorical differ-
ences, respectively. Age-adjusted prevalence estimates were 
calculated using the direct method, which were age adjusted 
to the 2005 Korean population [12]. Multivariate conditional 
logistic regression analysis was performed using PAD as the 
dependent variable and smoking, duration of diabetes, SBP, 
serum total cholesterol, and presence of microvascular or mac-
rovascular complication as the independent variables. The 
control group was selected using the stratified random sampling 
method to be matched for age and sex with the case group. A 
P value less than 0.05 was considered statistically significant. 
RESULTS
Prevalence of PAD
The overall prevalence of PAD in the patients was 3.2% (n=
64). The proportion of severe PAD among patients with PAD 
was 4.7% (n=3). The age-adjusted prevalence rate in the pop-
ulation [12] was 1.8%.
Comparative analysis of the prevalence of PAD according 
to age and sex
Baseline characteristics of the study population are presented 
in Table 1. Men comprised 58.5% of the subjects, and the mean 
age of the subjects was 59.5 years. The prevalence of PAD was 
4.3% and 1.7% in the male and female subjects, respectively. 
  Fig. 1 shows the prevalence rates of PAD according to age 
and sex. The trend for the increase according to age was statis-
tically significant in both sexes (P<0.001). PAD was more 
prevalent in male subjects than in female subjects, regardless 
of age. 
Characteristics of the PAD group
The mean age of the PAD group was 66.9±9.1 years, and 78.0% 
(n=50) were male (Table 2). When the clinical characteristics 
of these patients were compared with those of the age- and 
sex-matched control group, SBP and serum triglyceride levels 
were significantly higher in the PAD group than in the control 
group. A history of smoking was found in 65.6% and 54.2% of 
the PAD and control groups, respectively. The amount of smok-
ing was significantly higher in the PAD group than in the con-
trol group. No significant differences were found in duration 
of diabetes, BMI, FBS, 2hPG, HbA1c, C-peptide, total choles-
terol, LDL cholesterol or HDL cholesterol. The PAD group had 
higher rates of all microvascular and macrovascular complica-
tions than did the control group. More patients in the PAD 
group were being treated with medications for hypercholester-
olemia or hypertension. 
  Table 3 shows the odds ratio (OR) of PAD according to 
clinical status analyzed by univariate conditional logistic re-
gression analysis. Those with a diabetic duration ≥20 years 
had a significantly higher risk of PAD (OR, 2.08; 95% confi-
dence interval [CI], 1.08 to 4.01; P≤0.029). The OR for SBP 
≥140 mm Hg as a risk factor for PAD was 2.78 (95% CI, 1.51 
to 5.10; P≤0.001). The OR for smoking status as a risk factor 
for PAD was 2.30 (95% CI, 1.02 to 5.23; P≤0.046). 
  In order to determine the factors independently associated 
with PAD, we performed multivariate conditional logistic re-
gression analysis (Table 4). Presence of one or more compo-
nents of microvascular and macrovascular complications was 
Table 1.  Characteristics of the patients (n=2,002)
Characteristic Male Female
Total, n (%) 1,172 (58.5) 830 (41.5)
Mean age 58.1 61.4
Age distribution, n (%)
30-39 53 (4.5) 21 (2.5)
40-49 191 (16.3) 79 (9.5)
50-59 406 (34.6) 239 (28.8)
60-69 357 (30.5) 304 (36.6)
70-79 144 (12.3) 163 (19.6)
≥80 21 (1.8) 24 (2.9)
Fig. 1.  The prevalence rates of peripheral arterial disease ac-
cording to age and sex.
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Table 2.  Clinical characteristics of the study groups 
Risk factor PAD (n=64) No PAD (n=192) P value
a
Sex, M/F 50/14 150/42 1.000 
Age, yr 66.9±9.1 66.5±8.8 0.749
Duration of DM, yr 14.7±10.8 12.3±8.7 0.113
BMI, kg/m
2 24.8±3.1 24.8±2.9 0.989
Smoking status, % current or ex 65.6 54.2 0.109
Smoking amount, median pack-yr 25 10 0.017
SBP, mm Hg 134.9±17.7 127.8±15.0 0.002
DBP, mm Hg 71.2±9.9 70.2±8.7 0.456
FBS, mg/dL 138.1±42.2 134.2±36.8 0.478
2hPG, mg/dL 218.9±60.8 (n=64) 216.8±71.1 (n=190) 0.828
HgA1c, % 7.4±1.2 7.4±1.2 0.847
C-peptide, ng/mL 2.6±1.4 (n=63) 2.4±1.5 (n=189) 0.254
Total cholesterol, mg/dL 166.8±40.1 161.7±32.7 0.308
Triglyceride, mg/dL 163.4±99.5 138.6±71.8 0.032
HDL-C, mg/dL 43.4±12.1 46.1±11.3 0.105
LDL-C, mg/dL 99.7±31.6 97.1±28.9 0.541
DM management
Diet & exercise 1 (1.6) 5 (2.6) 0.383
OHA 47 (73.4) 156 (81.3) 0.383
Insulin+OHA 10 (15.6) 22 (11.4) 0.383
Insulin 6 (9.4) 9 (4.7) 0.383
Microvascular complication
Retinopathy 38 (59.4) 66 (34.3) <0.001
Nephropathy 38 (59.4) 46 (24.0) <0.001
Neuropathy 40 (63.0) 84 (44.0) 0.009
Macrovascular complication
CVA 20 (31.0) 17 (9.0) <0.001
CAD 30 (47.0) 35 (18.0) <0.001
Medication
Cholesterol-lowering drugs 49 (77) 107 (56) 0.003
Antihypertensive drugs 56 (88) 126 (66) 0.001
ABI
Right ABI 0.84±0.20 1.16±0.08 <0.001
Right baPWV, m/sec 17.18±4.99 17.27±3.55 0.887
Left ABI 0.82±0.21 1.15±0.08 <0.001
Left baPWV, m/sec 16.08±6.25 17.36±3.62 0.131
Values are presented as the mean±standard deviation or number (%). 
PAD, peripheral arterial disease; DM, diabetes mellitus; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBS, 
fasting blood sugar; 2hPG, plasma glucose two hours after a meal; HbA1c, hemoglobin A1c; HDL-C, high density lipoprotein cholesterol; 
LDL-C, low density lipoprotein cholesterol; OHA, oral hypoglycemic agent; CVA, cerebrovascular accident; CAD, coronary artery disease; 
ABI, ankle-brachial index; baPWV, brachial-ankle pulse wave velocity.
aP<0.05 was considered significant.547
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categorized as microvascular and macrovascular complica-
tion, respectively. Higher SBP and the presence of microvas-
cular and/or macrovascular complications were independent-
ly associated with PAD.
DISCUSSION
The prevalence of PAD in the general population has been re-
ported to be varied [6,13-15]. It is generally believed that dia-
betes increases the risk of PAD two- to four-fold [7]. Most of 
the previous data on the prevalence of PAD came from Euro-
peans or Americans. In a German population aged ≥65 years, 
subjects with diabetes had a higher prevalence of PAD in com-
parison with that of non-diabetics (26.3% vs. 15.3%) [16]. In a 
U.S. population aged 50 to 70 years, the prevalence of PAD in 
diabetic patients was 22.0% [17]. PAD was found in 21.1% of 
newly diagnosed type 2 diabetic Italian patients aged >30 
years [18]. 
  In our study, the prevalence of PAD in Korean type 2 dia-
betic patients aged ≥25 years was considerably lower (3.2%) 
than that in Western countries. The prevalence in patients ≥50 
years of age was 3.7% (men 5.2%, women 1.9%). In agreement 
with our study, a previous nationwide survey performed by 
the Committee of the Korean Diabetes Association on the Epi-
demiology of Diabetes Mellitus also reported that 3.0% of Ko-
rean diabetic patients attending 13 tertiary hospitals in Korea 
had PAD [19]. Similarly, the prevalence of PAD in an urban 
South Indian population was 3.2% in non-diabetic subjects 
and 6.3% in diabetic patients (≥20 years of age) [20]. Con-
versely, in the PAD-SEARCH study, an international study 
that investigated the prevalence of PAD in Asian type 2 diabetic 
patients (>50 years of age, having one or more risk factors for 
atherosclerosis), 17.7% of the patients had PAD [10]. The prev-
alence of PAD in Chinese diabetic patients (≥35 years of age) 
was even higher (32.2%) [21]. 
  The cause of these differences between studies performed in 
Asian populations is not known. In addition, the reason the 
results of our study demonstrated a lower prevalence of PAD 
in Korean type 2 diabetic patients than that in the Western 
population is not known. However, this may not be due to 
simple selection bias because the study subjects were random-
ly selected from patients attending a large university hospital. 
In this hospital, milder diabetic patients without apparent dia-
betic complications are usually referred back to private clinics. 
The hospital is located in the southern part of Seoul, and more 
than 70% of the patients come from urban areas. If the lower 
rate of PAD in Korean diabetic patients is real, this may be re-
lated to a lower prevalence of obesity, an important risk factor 
Table 3.  Odds ratios of PAD according to clinical status: results 
from univariate conditional logistic regression analysis
Risk factor OR 95% CI P value
a
Duration of DM
<20 yr 1.000  –
≥20 yr 2.080  1.079-4.009 0.029 
SBP 
<140 mm Hg 1.000  –
≥140 mm Hg 2.779  1.514-5.101 0.001 
Smoking status
Non-smoker 1.000  –
Past or current smoker 2.303  1.015-5.225 0.046 
Smoking, pack-yr
None 1.000
1-30 2.129 0.862-5.257 0.850
31-60 1.881 0.737-4.802 0.539
>60 6.305 1.720-23.102 0.017
Microvascular complication
Nephropathy 4.545  2.506-8.243 <0.001
Retinopathy 2.831  1.575-5.088 0.001 
Neuropathy 2.178  1.210-3.921 0.010 
Macrovascular complication
CVA 4.747  2.278-9.894 <0.001
CAD 4.188  2.227-7.875 <0.001
PAD, peripheral arterial disease; OR, odds ratio; CI, confidence inter-
val; DM, diabetes mellitus; SBP, systolic blood pressure; CVA, cere-
brovascular accident; CAD, coronary artery disease.
aP<0.05 was considered significant.
Table 4.  Adjusted odds ratios of PAD for various independent 
indicators: results from multivariate conditional logistic re-
gression analysis
Risk factor OR 95% CI P value
a
SBP ≥140 mm Hg 2.492  1.249-4.970 0.010 
Microvascular complication 6.156  2.270-16.695 <0.001
Macrovascular complication 5.319  2.689-10.523 <0.001
Included in the logistic regression model were smoking, duration of 
diabetes, SBP, serum total cholesterol, and presence of microvascular 
or macrovascular complication.
PAD, peripheral arterial disease; OR, odds ratio; CI, confidence inter-
val; SBP, systolic blood pressure.
aP<0.05 was considered significant.548
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for atherosclerosis, in this country [22]. Other previous stud-
ies [23,24] have shown associations between obesity and man-
ifestations of PAD among diabetic subjects. However, incidenc-
es of CAD and ischemic CVA are increasing in Asian popula-
tions due to the Westernization of life style [25-27]. It thus re-
mains to be seen whether the prevalence of PAD in Korean di-
abetic patients will increase in the future. 
  The prevalence of PAD in women is usually lower than that 
in men, and it has been suggested that onset of PAD in women 
usually starts 10 to 20 years later than that in men [28]. Accord-
ingly, the prevalence of PAD in women in our study was lower 
than that in men, and, in fact, no women <60 years of age had 
PAD. 
  As with previous studies [24,29-31], significant differences 
in SBP, triglyceride, and pack-years of smoking were found 
between subjects with and without PAD in our study. This 
finding suggests that these factors may be particularly impor-
tant in the development of PAD in diabetic populations. We 
did not find a significant difference in total, LDL- or HDL-cho-
lesterol level between patients with and without PAD. These re-
sults are inconsistent with the Framingham Study [32] and 
other studies [24,29,33]. It is possible that some of these differ-
ences in risk factors may be caused by cholesterol-lowering 
drugs. More patients in the PAD group in our study were tak-
ing medications for hypercholesterolemia, which may have 
masked the real differences in cholesterol. 
  It is well known that very strong associations exist between 
PAD and other atherosclerotic disorders [1-3]. However, inde-
pendent association of PAD with microvascular complications 
was not expected. According to the ticking clock hypothesis 
[34], the risk for CAD starts to increase long before the onset 
of clinical diabetes, while microvascular complications devel-
op only after the onset of diabetes. However, several previous 
studies also have shown that peripheral neuropathy [7], dia-
betic retinopathy [35,36] and renal insufficiency [37,38] are 
associated with PAD. This can be partly explained by the steno 
hypothesis [39], which posits that microvascular complica-
tions (i.e., albuminuria) reflect widespread vascular damages 
in the entire body.
  The present study has some limitations. First, our results 
were affected by a selection bias. The sample was not popula-
tion-based and consisted of individuals who visited a single 
large university hospital. In addition, our study did not include 
all diabetic patients who visited in our hospital during the study 
period. Second, because this study was cross-sectional, we 
were unable to determine whether risk factors were causally 
related to the ABI values. Third, we excluded the subjects with 
an ABI >1.4. Calcified, poorly compressible vessels in the el-
derly diabetic patients can artificially elevate values. The Strong 
Heart Study (SHS) recommended that ABI >1.4 should not be 
considered normal [40]. However, the overall prevalence of 
PAD would not have changed much (3.2% → 3.9%) even if 
these subjects were classified as having PAD.
  In summary, this study showed that the prevalence of PAD 
might be quite low in Korean patients with type 2 diabetes in 
comparison with that in Western countries. It remains to be 
seen whether Westernization will increase the prevalence of 
PAD in Korean diabetic patients in the future.
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